Literature DB >> 23810829

Intrathecal P/Q- and R-type calcium channel blockade of spinal substance P release and c-Fos expression.

Tetsuji Terashima1, Qinghao Xu2, Shigeki Yamaguchi3, Tony L Yaksh4.   

Abstract

Intrathecal (IT) studies have shown that several voltage sensitive calcium channels (VSCCs), such as the L-, N- and T-type may play roles in nociception and that of these only the N-type regulates primary afferent substance P (SP) release. However, the actions of other VSCCs at the spinal level are not well known. We investigated the roles of spinal P/Q- and R-type VSCCs, by IT administration of R-type (SNX-482) and P/Q-type (ω-agatoxin IVA) VSCC blockers on intraplantar formalin-evoked flinching, SP release from primary afferents and c-Fos expression in spinal dorsal horn. Intraplantar injection of formalin (2.5%, 50 μL) produced an intense, characteristic biphasic paw flinching response. In rats with IT catheters, IT SNX-482 (0.5 μg) reduced formalin-evoked paw flinching in both phase 1 and 2 compared with vehicle. Intraplantar formalin caused robust neurokinin 1 receptor (NK1r) internalization (indicating SP release) and c-Fos expression in the ipsilateral dorsal horn, which were blocked by IT SNX-482. IT ω-agatoxin IVA (0.03, 0.125 and 0.5 μg) did not reduce formalin-evoked paw flinching or c-Fos expression at any doses, with higher doses resulting in motor dysfunction. Thus, we demonstrated that blockade of spinal R-type, but not P/Q type VSCCs attenuated formalin-induced pain behavior, NK1r internalization and c-Fos expression in the superficial dorsal horn. This study supports a role for Cav2.3 in presynaptic neurotransmitter release from peptidergic nociceptive afferents and pain behaviors.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CGRP; DRG; G protein-coupled receptor; GPCR; IB4; IR; IT; N-methyl-d-aspartate; NK1r; NMDA; Neurokinin 1 receptor; SNX-482; SP; Spinal cord; TRPV1; VSCCs; Voltage sensitive calcium channels; c-Fos; calcitonin gene-related peptide; dorsal root ganglia; immunoreactive; intrathecal; isolectin B4; neurokinin 1 receptor; substance P; transient receptor potential protein vanilloid 1; trkA; tropomyosin receptor kinase A; voltage-sensitive calcium channels; ω-Agatoxin IVA

Mesh:

Substances:

Year:  2013        PMID: 23810829      PMCID: PMC3865027          DOI: 10.1016/j.neuropharm.2013.06.018

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  52 in total

1.  Nomenclature of voltage-gated calcium channels.

Authors:  E A Ertel; K P Campbell; M M Harpold; F Hofmann; Y Mori; E Perez-Reyes; A Schwartz; T P Snutch; T Tanabe; L Birnbaumer; R W Tsien; W A Catterall
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

Review 2.  Structure and regulation of voltage-gated Ca2+ channels.

Authors:  W A Catterall
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

3.  P-type calcium channels blocked by the spider toxin omega-Aga-IVA.

Authors:  I M Mintz; V J Venema; K M Swiderek; T D Lee; B P Bean; M E Adams
Journal:  Nature       Date:  1992-02-27       Impact factor: 49.962

4.  Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor.

Authors:  P W Mantyh; S D Rogers; P Honore; B J Allen; J R Ghilardi; J Li; R S Daughters; D A Lappi; R G Wiley; D A Simone
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

5.  Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals.

Authors:  R E Westenbroek; L Hoskins; W A Catterall
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

6.  Induction of c-fos-like protein in spinal cord neurons following sensory stimulation.

Authors:  S P Hunt; A Pini; G Evan
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

7.  Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways.

Authors:  Rie Suzuki; Sara Morcuende; Mark Webber; Stephen P Hunt; Anthony H Dickenson
Journal:  Nat Neurosci       Date:  2002-12       Impact factor: 24.884

8.  Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C.

Authors:  Jill C Fehrenbacher; Charles P Taylor; Michael R Vasko
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

9.  Activation of protein kinase C augments peptide release from rat sensory neurons.

Authors:  L A Barber; M R Vasko
Journal:  J Neurochem       Date:  1996-07       Impact factor: 5.372

10.  Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine.

Authors:  K R Gogas; H J Cho; G I Botchkina; J D Levine; A I Basbaum
Journal:  Pain       Date:  1996-04       Impact factor: 6.961

View more
  14 in total

1.  Surfen is a broad-spectrum calcium channel inhibitor with analgesic properties in mouse models of acute and chronic inflammatory pain.

Authors:  Paula Rivas-Ramirez; Vinicius M Gadotti; Gerald W Zamponi; Norbert Weiss
Journal:  Pflugers Arch       Date:  2017-06-30       Impact factor: 3.657

Review 2.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

3.  High-Voltage-Activated Calcium Channel in the Afferent Pain Pathway: An Important Target of Pain Therapies.

Authors:  Qi Li; Jian Lu; Xiaoxin Zhou; Xuemei Chen; Diansan Su; Xiyao Gu; Weifeng Yu
Journal:  Neurosci Bull       Date:  2019-05-07       Impact factor: 5.203

Review 4.  Targeting voltage-gated calcium channels in neurological and psychiatric diseases.

Authors:  Gerald W Zamponi
Journal:  Nat Rev Drug Discov       Date:  2015-11-06       Impact factor: 84.694

5.  Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.

Authors:  Jennifer Y Xie; Lindsey A Chew; Xiaofang Yang; Yuying Wang; Chaoling Qu; Yue Wang; Lauren M Federici; Stephanie D Fitz; Matthew S Ripsch; Michael R Due; Aubin Moutal; May Khanna; Fletcher A White; Todd W Vanderah; Philip L Johnson; Frank Porreca; Rajesh Khanna
Journal:  Pain       Date:  2016-09       Impact factor: 7.926

6.  Electrophysiological characterization of activation state-dependent Ca(v)2 channel antagonist TROX-1 in spinal nerve injured rats.

Authors:  R Patel; K Rutten; M Valdor; K Schiene; S Wigge; S Schunk; N Damann; T Christoph; A H Dickenson
Journal:  Neuroscience       Date:  2015-04-01       Impact factor: 3.590

Review 7.  Current status and future directions of botulinum neurotoxins for targeting pain processing.

Authors:  Sabine Pellett; Tony L Yaksh; Roshni Ramachandran
Journal:  Toxins (Basel)       Date:  2015-11-04       Impact factor: 4.546

8.  Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation.

Authors:  Géza Berecki; Jeffrey R McArthur; Hartmut Cuny; Richard J Clark; David J Adams
Journal:  J Gen Physiol       Date:  2014-04       Impact factor: 4.086

9.  miR-34c-5p functions as pronociceptive microRNA in cancer pain by targeting Cav2.3 containing calcium channels.

Authors:  Jagadeesh Gandla; Santosh Kumar Lomada; Jianning Lu; Rohini Kuner; Kiran Kumar Bali
Journal:  Pain       Date:  2017-09       Impact factor: 7.926

10.  α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors.

Authors:  Joel Castro; Andrea M Harrington; Sonia Garcia-Caraballo; Jessica Maddern; Luke Grundy; Jingming Zhang; Guy Page; Paul E Miller; David J Craik; David J Adams; Stuart M Brierley
Journal:  Gut       Date:  2016-02-17       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.